Literature DB >> 17994433

Spinal cord lesions of progressive multifocal leukoencephalopathy in an acquired immunodeficiency syndrome patient.

F Bernal-Cano1, J T Joseph, I J Koralnik.   

Abstract

Progressive multifocal leukoencephalopathy (PML) is a deadly demyelinating disease of the central nervous system, which occurs in immunosuppressed individuals. This disease is caused by a reactivation of the polyomavirus JC (JCV). Clinical presentation can be variable from patient to patient as lesions can occur anywhere in the CNS white matter; however, they appear to spare the optic nerves and the spinal cord. The authors present a case of PML in the setting of acquired immunodeficiency syndrome (AIDS) who developed PML lesions in the spinal cord, discovered during the postmortem examination. This finding is significant because PML has recently been diagnosed in patients with multiple sclerosis (MS) treated with the novel immunomodulatory medication natalizumab. Indeed, spinal cord lesions are frequent in MS. Therefore clinicians should be aware that in addition to the brain, PML may also affect the spinal cord white matter.

Entities:  

Mesh:

Year:  2007        PMID: 17994433     DOI: 10.1080/13550280701469178

Source DB:  PubMed          Journal:  J Neurovirol        ISSN: 1355-0284            Impact factor:   2.643


  7 in total

1.  Progressive multifocal leukoencephalopathy and natalizumab--unforeseen consequences.

Authors:  Joseph R Berger; Igor J Koralnik
Journal:  N Engl J Med       Date:  2005-06-09       Impact factor: 91.245

2.  Progressive multifocal leukoencephalopathy in a patient treated with natalizumab.

Authors:  Annette Langer-Gould; Scott W Atlas; Ari J Green; Andrew W Bollen; Daniel Pelletier
Journal:  N Engl J Med       Date:  2005-06-09       Impact factor: 91.245

3.  Progressive multifocal leukoencephalopathy complicating treatment with natalizumab and interferon beta-1a for multiple sclerosis.

Authors:  B K Kleinschmidt-DeMasters; Kenneth L Tyler
Journal:  N Engl J Med       Date:  2005-06-09       Impact factor: 91.245

Review 4.  Progressive multifocal leukoencephalopathy revisited: Has the disease outgrown its name?

Authors:  Igor J Koralnik
Journal:  Ann Neurol       Date:  2006-08       Impact factor: 10.422

5.  Analysis of the systemic and intrathecal humoral immune response in progressive multifocal leukoencephalopathy.

Authors:  T Weber; C Trebst; S Frye; P Cinque; L Vago; C J Sindic; W J Schulz-Schaeffer; H A Kretzschmar; W Enzensberger; G Hunsmann; W Lüke
Journal:  J Infect Dis       Date:  1997-07       Impact factor: 5.226

6.  Infection with JC virus and possible dysplastic ganglion-like transformation of the cerebral cortical neurons in a case of progressive multifocal leukoencephalopathy.

Authors:  M Shintaku; R Matsumoto; H Sawa; K Nagashima
Journal:  J Neuropathol Exp Neurol       Date:  2000-10       Impact factor: 3.685

Review 7.  Progressive multifocal leukoencephalopathy in AIDS: a clinicopathologic study and review of the literature.

Authors:  R W von Einsiedel; T D Fife; A J Aksamit; M E Cornford; D L Secor; U Tomiyasu; H H Itabashi; H V Vinters
Journal:  J Neurol       Date:  1993-07       Impact factor: 4.849

  7 in total
  18 in total

Review 1.  Progressive multifocal leukoencephalopathy and other disorders caused by JC virus: clinical features and pathogenesis.

Authors:  Chen S Tan; Igor J Koralnik
Journal:  Lancet Neurol       Date:  2010-04       Impact factor: 44.182

Review 2.  Diagnostic assays for polyomavirus JC and progressive multifocal leukoencephalopathy.

Authors:  Martyn K White; Ilker K Sariyer; Jennifer Gordon; Serena Delbue; Valeria Pietropaolo; Joseph R Berger; Kamel Khalili
Journal:  Rev Med Virol       Date:  2015-12-14       Impact factor: 6.989

3.  Natalizumab in the treatment of multiple sclerosis.

Authors:  Ozgür Yaldizli; Norman Putzki
Journal:  Ther Adv Neurol Disord       Date:  2009-03       Impact factor: 6.570

4.  JC virus infection of the brain.

Authors:  A K Bag; J K Curé; P R Chapman; G H Roberson; R Shah
Journal:  AJNR Am J Neuroradiol       Date:  2010-03-18       Impact factor: 3.825

5.  Spinal cord progressive multifocal leukoencephalopathy detected premortem by MRI.

Authors:  Roger Murayi; James Schmitt; John H Woo; Joseph R Berger
Journal:  J Neurovirol       Date:  2015-07-03       Impact factor: 2.643

Review 6.  PML diagnostic criteria: consensus statement from the AAN Neuroinfectious Disease Section.

Authors:  Joseph R Berger; Allen J Aksamit; David B Clifford; Larry Davis; Igor J Koralnik; James J Sejvar; Russell Bartt; Eugene O Major; Avindra Nath
Journal:  Neurology       Date:  2013-04-09       Impact factor: 9.910

Review 7.  Progressive multifocal leukoencephalopathy in pediatric patients: case report and literature review.

Authors:  Hayden Schwenk; Lynn Ramirez-Avila; Shu-Hsien Sheu; Christian Wuthrich; Jeff Waugh; Adam Was; Umberto Degirolami; Sandra Burchett; Igor J Koralnik; Asim Ahmed
Journal:  Pediatr Infect Dis J       Date:  2014-04       Impact factor: 2.129

8.  Simian Virus 40 Infection in the Spinal Cord of Simian Immunodeficiency Virus-Immunosuppressed Rhesus Macaques.

Authors:  Saravanan Kaliyaperumal; Christian Wüthrich; Susan V Westmoreland; Igor J Koralnik
Journal:  J Neuropathol Exp Neurol       Date:  2015-11       Impact factor: 3.685

Review 9.  Progressive multifocal leukoencephalopathy and other forms of JC virus disease.

Authors:  Bruce J Brew; Nicholas W S Davies; Paola Cinque; David B Clifford; Avindra Nath
Journal:  Nat Rev Neurol       Date:  2010-12       Impact factor: 42.937

Review 10.  Progressive multifocal leukoencephalopathy in HIV-1 infection.

Authors:  Paola Cinque; Igor J Koralnik; Simonetta Gerevini; Jose M Miro; Richard W Price
Journal:  Lancet Infect Dis       Date:  2009-10       Impact factor: 25.071

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.